预测老年结直肠癌患者严重毒性及死亡风险:三项临床试验与三项前瞻性队列分析
转移患者12个月死亡独立因素包括IADL受损、中性粒细胞升高及白蛋白降低,联合模型AUC为0.691。
要点
- 女性、男性认知障碍、双药化疗、单药化疗低白蛋白及低肾小球滤过率为严重毒性独立危险因素。
- 转移患者12个月死亡独立因素为IADL受损、中性粒细胞升高及白蛋白降低。
核心结论
- 汇总六项针对老年结直肠癌患者的研究,识别出与严重毒性及死亡相关的临床和生物学因素。
- 若经外部验证,这些发现可能有助于个体化治疗决策。
研究设计与样本
- 分析三项前瞻性队列和三项临床试验,纳入年龄≥75岁的结直肠癌患者。
- 严重毒性定义为≥3级毒性。
- 采用多因素logistic回归评估严重毒性相关因素,多因素Cox比例风险模型评估死亡相关因素。
主要发现
- 严重毒性独立危险因素:女性、男性认知障碍、双药化疗、接受单药化疗患者低白蛋白水平、低肾小球滤过率。
临床怎么用
- 对≥75岁结直肠癌患者,可评估女性、认知障碍(男性)、双药化疗、单药化疗时低白蛋白及低肾小球滤过率等严重毒性危险因素。
- 对转移性患者,可关注IADL受损、中性粒细胞升高及低白蛋白以评估12个月死亡风险。
- 上述预测模型需外部验证后方可用于个体化治疗决策。
局限性
- 预测模型需外部验证确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Patients over 75 years old account for 40% of incident colorectal cancer (CRC) cases. Predicting chemotherapy (CT)-related toxicities is crucial for guiding treatment decisions. This study aimed to identify predictors of severe toxicities (ST) after 3 months of CT in older CRC patients; the secondary endpoint was 36-month mortality. MATERIALS AND METHODS: We analyzed three prospective cohorts and three trials involving patients aged ≥ 75 years. ST was defined as grade ≥ 3 toxicity. Multivariable logistic regression was used to assess factors associated with ST. For mortality, a multivariable Cox proportional hazards model was used. RESULTS: 777 patients were included, with a median age of 80·3 years. 20·6% had ECOG-PS > 2, 20·8% had impaired independence for essential activities of daily living (ADL<6), and 46% had impaired IADL (<8). 48·4% had metastatic disease and 45·0% received doublet CT. ST occurred in 25·0% and 43·7% of patients in cohorts and trials, respectively. The independent risk factors for ST were: female sex, cognitive impairment in men, doublet CT, low albumin level in patients receiving single-agent CT, and low glomerular filtration rate. A model combining these parameters had an AUC of 0·700. The independent factors associated with 12-month mortality among metastatic patients were: impaired IADL, higher neutrophil count, and lower albumin. A model combining these variables with targeted therapy use and a history of primary tumor surgery achieved an AUC of 0.691. DISCUSSION: By pooling six trials and cohorts dedicated to older CRC patients, we identified clinical and biological factors associated with ST and mortality. If confirmed through external validation, these findings may inform personalized treatment decisions.
引用
- Rémond M, Aparicio T, Martinez-Tapia C, et al. Predicting severe toxicities and mortality in older patients with colorectal cancer: An analysis of 3 clinical trials and 3 prospective cohorts. Eur J Cancer. 2026. PMID: 42456539. doi:10.1016/j.ejca.2026.116935
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。